Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
Recruiting now
Conditions studied: Biliary Tract Cancer
In brief
The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy, targeted therapy,loco-regional treatments ) in patients with bile duct cancer. The effectiveness and tolerance of these treatments in current practice will also be evaluated.
Key facts
- Study ID
- NCT04935853
- Run by
- GERCOR - Multidisciplinary Oncology Cooperative Group
- People needed
- 1350
- Starts
- 2022-05-23
- Expected to finish
- 2040-06-01
- Last updated by the study team
- 2025-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All locations of primitives (intrahepatic CCA, extrahepatic CCA, adenocarcinoma of the gallbladder; ampullomas excluded)
- Age > 18 years
- Diagnosed between 2003 and 2030 (minimum follow-up 2 years)
- Written written non-opposition +/- signed informed consent for genetic studies (N.B.:
- exemption requested for a deceased patient) N.B. Authorized inclusion in a therapeutic research protocol
You may not qualify if…
- Patient under guardianship, curatorship or legal protection
- Pregnant or breastfeeding women
- Any medical, psychological or social situation, which could prevent the compliance with the protocol according to the investigator's assessment
- Refusal to participate in the study
Where it is running
- CHU Hôpital Sud Amiens — Amiens, France (enrolling)
- CHU Angers — Angers, France (enrolling)
- CHU Besançon — Besançon, France (enrolling)
- Hôpital Avicenne — Bobigny, France (enrolling)
- CHU - Henri Mondor — Créteil, France (enrolling)
- CHU Dijon — Dijon, France (enrolling)
- CHU Grenoble — Grenoble, France (enrolling)
- CHU Lille — Lille, France (enrolling)
- Centre Léon Bérard — Lyon, France (enrolling)
- Hôpital Croix Rousse — Lyon, France (enrolling)
- Hôpital Edouard Herriot — Lyon, France (enrolling)
- Hôpital Privé Jean Mermoz — Lyon, France (enrolling)
- Institut Paoli Calmette — Marseille, France (enrolling)
- CHU Saint Eloi Montpellier — Montpellier, France (enrolling)
- CHR Orléans — Orléans, France (enrolling)
- Groupe Hospitalier Pitié Salpêtrière — Paris, France (enrolling)
- Hôpital Ambroise Paré — Paris, France (enrolling)
- Hôpital Cochin — Paris, France (enrolling)
- Hôpital Saint Antoine — Paris, France (enrolling)
- Hôpital Saint Louis — Paris, France (enrolling)
- Institut Mutualiste Montsouris — Paris, France (enrolling)
- Hôpital Haut Lévêque — Pessac, France (enrolling)
- CHU Poitiers — Potiers, France (enrolling)
- Hôpital Robert Debré -CHU Reims — Reims, France (enrolling)
- Centre Eugène Marquis — Rennes, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.